Revvity logo

RevvityNYSE: RVTY

Profile

Sector:

Healthcare

Country:

United States

IPO:

06 July 1965

Next earnings report:

31 January 2025

Last dividends:

18 October 2024

Next dividends:

17 January 2025
$13.63 B
-46%vs. 3y high
94%vs. sector
-42%vs. 3y high
80%vs. sector
-51%vs. 3y high
52%vs. sector
-23%vs. 3y high
61%vs. sector

Price

after hours | Thu, 21 Nov 2024 00:49:55 GMT
$112.00+$0.63(+0.57%)
$684.05 M$730.56 M
$684.05 M$94.37 M

Analysts recommendations

Institutional Ownership

RVTY Latest News

RVTY Q3 Earnings & Revenues Beat Estimates, Guidance Revised
zacks.com04 November 2024 Sentiment: POSITIVE

Revvity's results for the third quarter show significant growth in their Diagnostics business, but there has been a drop in sales in the Life Sciences sector.

Revvity (RVTY) Surpasses Q3 Earnings and Revenue Estimates
zacks.com04 November 2024 Sentiment: POSITIVE

Revvity (RVTY) reported quarterly earnings of $1.28 per share, which is higher than the Zacks Consensus Estimate of $1.13 per share. This is an increase compared to earnings of $1.18 per share from the same period last year.

Revvity Announces Financial Results for the Third Quarter of 2024
businesswire.com04 November 2024 Sentiment: POSITIVE

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) has announced its financial results for the third quarter ending September 29, 2024. The company reported earnings per share of $0.77, up from $0.08 during the same quarter last year. Additionally, GAAP revenue for this quarter was $684 million, compared to $671 million in the previous year, with an operating income of $98 million, rising from $69 million a year ago.

Revitty (RVTY) Q3 2024 Earnings Call Transcript
seekingalpha.com04 November 2024 Sentiment: POSITIVE

Revitty Incorporated (NYSE:RVTY) will hold its Q3 2024 earnings conference call on November 4, 2024, at 8:00 AM ET. The call will feature company leaders including Prahlad Singh, the CEO, and Max Krakowiak, the CFO, along with various participants from major financial institutions. The operator, Lydia, will welcome everyone to the call.

Revvity to Report Q3 Earnings: What's in Store for the Stock?
zacks.com01 November 2024 Sentiment: POSITIVE

RVTY's results for the third quarter are expected to show good performance in the Diagnostics area, but the Life Sciences sector may continue to struggle in China.

Revvity Shares Decline Despite Launch of Transcribe AI Solution
zacks.com23 October 2024 Sentiment: POSITIVE

RVTY has launched Transcribe AI, a tool that converts handwritten test request forms into digital format. This innovation speeds up workflows and minimizes mistakes in data entry.

RVTY's Latest Launch to Enable APOE Genotyping of Alzheimer's Disease
zacks.com10 October 2024 Sentiment: POSITIVE

Revvity's new solution for accurately typing the AD-related APOE gene may help evaluate a patient's risk of negative effects from new anti-amyloid treatments for Alzheimer's.

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
zacks.com07 October 2024 Sentiment: POSITIVE

RVTY's ongoing commitment to innovation and a solid range of products creates a positive outlook for the stock.

Reasons to Retain Revvity Stock in Your Portfolio for Now
zacks.com06 September 2024 Sentiment: POSITIVE

RVTY has a solid range of products, which makes people feel positive about the stock.

MD or RVTY: Which Is the Better Value Stock Right Now?
zacks.com26 August 2024 Sentiment: NEUTRAL

Investors looking at Medical Services stocks probably know about Pediatrix Medical Group (MD) and Revvity (RVTY). However, which of these two stocks offers a better value opportunity for investors at this moment?

  • 1(current)
  • 2
  • 3

What type of business is Revvity?

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

What sector is Revvity in?

Revvity is in the Healthcare sector

What industry is Revvity in?

Revvity is in the Diagnostics & Research industry

What country is Revvity from?

Revvity is headquartered in United States

When did Revvity go public?

Revvity initial public offering (IPO) was on 06 July 1965

What is Revvity website?

https://www.revvity.com

Is Revvity in the S&P 500?

Yes, Revvity is included in the S&P 500 index

Is Revvity in the NASDAQ 100?

No, Revvity is not included in the NASDAQ 100 index

Is Revvity in the Dow Jones?

No, Revvity is not included in the Dow Jones index

When was Revvity the previous earnings report?

No data

When does Revvity earnings report?

The next expected earnings date for Revvity is 31 January 2025